pd168393 has been researched along with Astrocytosis in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PD168393 was used to inhibit EGFR signaling activation." | 1.40 | Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. ( Li, JJ; Li, ZW; Mao, XQ; Shi, GF; Wang, F; Wang, L; Wang, Q; Wu, JJ; Zhang, JP; Zou, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZW | 1 |
| Li, JJ | 1 |
| Wang, L | 1 |
| Zhang, JP | 1 |
| Wu, JJ | 1 |
| Mao, XQ | 1 |
| Shi, GF | 1 |
| Wang, Q | 1 |
| Wang, F | 1 |
| Zou, J | 1 |
1 other study available for pd168393 and Astrocytosis
| Article | Year |
|---|---|
Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury.
Topics: Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Expl | 2014 |